enVVeno Medical Corporation (NASDAQ: NVNO)
$3.3900
+0.0900 ( +2.73% ) 44.6K
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Market Data
Open
$3.3900
Previous close
$3.3000
Volume
44.6K
Market cap
$58.92M
Day range
$3.2950 - $3.4300
52 week range
$3.0120 - $6.9700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |
8-k | 8K-related | 14 | Nov 16, 2023 |